Globus Medical Inc. [NYSE: GMED] plunged by -$3.94 during the normal trading session on Thursday and reaching a high of $51.04 during the day while it closed the day at $48.68. Globus Medical Inc. stock has also loss -7.70% of its value over the past 7 days. However, GMED stock has inclined by 26.54% in the 3 months of the year. Over the past six months meanwhile, it has lost -14.40% and lost -17.32% year-on date.
The market cap for GMED stock reached $4.49 billion, with 99.64 million shares outstanding and 73.14 million shares in the current float. Compared to the average trading volume of 1.21M shares, GMED reached a trading volume of 1605050 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Here’s what leading stock market gurus have to say about Globus Medical Inc. [GMED]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GMED shares is $57.33 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GMED stock is a recommendation set at 2.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Needham have made an estimate for Globus Medical Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on May 08, 2020. The new note on the price target was released on March 18, 2020, representing the official price target for Globus Medical Inc. stock. Previously, the target price had yet another raise to $67, while SunTrust analysts kept a Buy rating on GMED stock.
The Average True Range (ATR) for Globus Medical Inc. is set at 2.38, with the Price to Sales ratio for GMED stock in the period of the last 12 months amounting to 5.67. The Price to Book ratio for the last quarter was 3.56, with the Price to Cash per share for the same quarter was set at 3.00. Price to Free Cash Flow for GMED in the course of the last twelve months was 40.79 with Quick ratio for the last quarter at 4.40.
GMED stock trade performance evaluation
Globus Medical Inc. [GMED] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.70. With this latest performance, GMED shares gained by 5.62% in over the last four-week period, additionally sinking by -14.40% over the last 6 months – not to mention a rise of 18.47% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GMED stock in for the last two-week period is set at 41.50, with the RSI for the last a single of trading hit 33.80, and the three-weeks RSI is set at 46.55 for Globus Medical Inc. [GMED]. The present Moving Average for the last 50 days of trading for this stock 48.51, while it was recorded at 53.09 for the last single week of trading, and 50.94 for the last 200 days.
Globus Medical Inc. [GMED]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Globus Medical Inc. [GMED] shares currently have an operating margin of +22.51 and a Gross Margin at +75.33. Globus Medical Inc.’s Net Margin is presently recorded at +19.76.
Return on Total Capital for GMED is now 13.65, given the latest momentum, and Return on Invested Capital for the company is 11.99. Return on Equity for this stock inclined to 11.99, with Return on Assets sitting at 10.96. When it comes to the capital structure of this company, Globus Medical Inc. [GMED] has a Total Debt to Total Equity ratio set at 0.18. Additionally, GMED Total Debt to Total Capital is recorded at 0.18, with Total Debt to Total Assets ending up at 0.16. Long-Term Debt to Equity for the company is recorded at 0.08, with the Long-Term Debt to Total Capital now at 0.08.
Reflecting on the efficiency of the workforce at the company, Globus Medical Inc. [GMED] managed to generate an average of $77,605 per employee. Receivables Turnover for the company is 5.12 with a Total Asset Turnover recorded at a value of 0.55.Globus Medical Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.40 and a Current Ratio set at 6.60.
Earnings per share (EPS) analysis for Globus Medical Inc. [GMED] stock
With the latest financial reports released by the company, Globus Medical Inc. posted 0.41/share EPS, while the average EPS was predicted by analysts to be reported at 0.41/share. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GMED. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Globus Medical Inc. go to 10.55%.
Globus Medical Inc. [GMED]: Insider Ownership positions
The top three institutional holders of GMED stocks are: BLACKROCK INC. with ownership of 9,443,830, which is approximately -1.802% of the company’s market cap and around 1.56% of the total institutional ownership; VANGUARD GROUP INC, holding 7,468,492 shares of the stock with an approximate value of $100.83 million in GMED stocks shares; and JANUS HENDERSON GROUP PLC, currently with $91.4 million in GMED stock with ownership of nearly -1.67% of the company’s market capitalization.